Centegra Health System announced plans to extend its
) to build an accountable care organization (ACO) delivery model
and benefit from the latter's comprehensive portfolio of revenue
Per the new agreement, Centegra will employ multiple MedAssets
solutions beyond the use of its supply chain solutions. The company
will now use MedAssets' Revenue Cycle Performance, Recovery and
Collections, Patient Access, Claims & Billing and Contract
& Episode Management solutions.
Drawing on these solutions, Centegra expects to optimize revenues
and efficiency, overcome increased margin pressures, assume greater
risk and manage complex coding and payor contracting.
With the ongoing market and regulatory changes impacting hospital
reimbursement, healthcare providers are shifting their focus to
build ACO delivery models. Significant changes in payment structure
are forcing providers to make use of third-party resources with
expertise in core business operations to remain cash positive.
MedAssets' technology and specialized consulting services will be
utilized by Centegra to improve revenue cycle operations, gain
greater efficiency in the financial clearing process and prepare
for reimbursement changes.
To cash in on the current demand, Centegra will engage MedAssets'
technology to optimize financial and operational performance under
current reimbursement models, while preparing for the transition to
ACO and other value-based models.
Last month, MedAssets introduced Contract Analytics - the first
module of Revenue Cycle Analytics, which is a robust analytical
discovery product suite designed to improve revenue cycle
efficiency and visibility into reimbursement performance. Sentara
Healthcare, a non-profit health system based in Virginia, was among
the first health systems to adopt MedAssets' Contract Analytics
MedAssets continues to build upon its wide array of proprietary
data and analytics tools by offering innovative solutions to
healthcare providers that are aiming for enhanced quality care,
operational efficiency and improved financial performance.
Currently, MedAssets carries a Zacks Rank #3 (Hold). Better-ranked
stocks in the medical services industry include
PAREXEL International Corp.
Quintiles Transnational Holdings Inc.
Charles River Laboratories International, Inc.
Both PAREXEL International and Quintiles Transnational Holdings
sport a Zacks Rank #1 (Strong Buy), while Charles River
Laboratories International carries a Zack Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
MEDASSETS INC (MDAS): Free Stock Analysis
QUINTILES TRANS (Q): Free Stock Analysis Report
CHARLES RVR LAB (CRL): Free Stock Analysis
PAREXEL INTL CP (PRXL): Free Stock Analysis
To read this article on Zacks.com click here.